Last month Indian generic drug giant Ranbaxy Inc. was hit with a $500 million fine—the largest penalty ever against any generic company— after reaching an agreement with the Department of Justice. The penalty resulted from the sale of several common drugs which Ranbaxy knew were of substandard quality. As part of the agreement, the company [...]
The post Not pretty: Derek Lowe’s interview on the Ranbaxy generic drug scandal appeared first on Health & Science Dispatch.
The post Not pretty: Derek Lowe’s interview on the Ranbaxy generic drug scandal appeared first on ACSH.
